Entertainment Wire Massachusetts: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Entertainment Wire Massachusetts.

Press releases published on June 1, 2026

Jun. 1, 2026

7AI Launches Threat Hunt, Threat Intel Hunt, and Skills, Giving Security Teams the Power to Make AI Agents Work Their Way

Indeterminate GlobeNewswire

Jun. 1, 2026

Rapid7 Appoints Wael Mohamed Chief Executive Officer; Corey Thomas to Become Executive Chairman

Indeterminate GlobeNewswire

Jun. 1, 2026

Intellia Therapeutics to Report Additional Phase 3 HAELO Data for Lonvoguran Ziclumeran (lonvo-z) in Late-Breaking Oral Presentation at EAACI 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

Immuneering Presents Compelling 17.3-Month Median Overall Survival and Favorable Tolerability with Atebimetinib + Chemotherapy in First-Line Pancreatic Cancer Patients at ASCO

Indeterminate GlobeNewswire

Jun. 1, 2026

Qantas, Oatly and Kingspan Executives Join Sustainability LIVE Leadership Summit at London Climate Action Week

Indeterminate GlobeNewswire

Jun. 1, 2026

Jade Biosciences Announces Positive Interim Phase 1 Results for JADE101 Demonstrating Potential Best-in-Class Profile and Every-12-Week Dosing in IgA Nephropathy

Indeterminate GlobeNewswire

Jun. 1, 2026

Liberty Global Names Stephen Van Rooyen as New Ziggo Group CEO Ahead of Planned Amsterdam Listing in 2027

Indeterminate GlobeNewswire

Jun. 1, 2026

Parsons Advances U.S. Air Force Innovation With $99 Million Task Order

Indeterminate GlobeNewswire

Jun. 1, 2026

Rejuvenate Biomed Completes Recruitment in Phase 2 Trial Assessing First-in-Class Multi-Pathway Therapeutic RJx-01 in COPD-Induced Sarcopenia

Indeterminate GlobeNewswire

Jun. 1, 2026

Auddia’s Discovr Radio Forms AI-Driven Partnership With Beatcave to Expand Independent Artist Discovery Across Canada

Indeterminate GlobeNewswire

Jun. 1, 2026

Vancouver’s Published on Main Named No.17 in North America’s 50 Best Restaurants 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

Agios Enters Exclusive Global License Agreement with Oscotec to Develop and Commercialize Next-Generation SYK Inhibitor Cevidoplenib

Indeterminate GlobeNewswire

Jun. 1, 2026

UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus

Indeterminate GlobeNewswire